Fundz

Revalesio Corp reported raising $6 Million in an initial SEC Form D filing, from an offering of $12 Million

PRIVATEJun 27, 2018

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Jun 27, 2018)

Round Type

Venture

TacomaBiotechnologyHealthcareHealth Care

Who to call at Revalesio, and when

A new round usually means Revalesio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Revalesio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Revalesio, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Revalesio

Location

1202 E. D ST

Tacoma, Washington, United States

About

Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies address cellular imbalances related to mitochondrial dysfunction and thereby modulate the immune response. They have been shown to protect neurons in models of chronic neurological diseases and improve recovery in acute neurological injury. We are partnering with internationally renowned scientists in biomedical research in a concerted effort to improve the lives of millions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Revalesio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEric R., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Revalesio's next move

See what Strategic adds

Revalesio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.